This article is educational and is not medical advice.
A standard testosterone test measures the concentration of testosterone circulating in your blood at the moment the sample is taken, reported as total testosterone in nanograms per decilitre (ng/dL) in most labs.
That word total matters. Testosterone does not float freely through the bloodstream. Most of it travels bound to two proteins. Sex hormone binding globulin (SHBG) holds it tightly, albumin holds it loosely, and a small remainder circulates unbound. Total testosterone adds all three together into one number. Because binding proteins change with age, body composition, thyroid status, liver health, alcohol intake and oestrogen exposure, two people with identical total testosterone can have quite different amounts of hormone available to tissue.
That is why clinicians often pair the total with SHBG and with free or bioavailable testosterone. Work on the biochemical assessment of androgen status has long argued that free or bioavailable fractions give a more faithful picture than total alone when binding proteins are shifted[1].
The test is a snapshot, not a verdict. Testosterone is released in pulses through the day and follows a daily rhythm, so the number on your report describes one moment in a moving system. A good testing process is designed to take that snapshot at the most comparable, most informative moment, and to repeat it before anyone draws conclusions.
Related: Do You Need to Fast for a Testosterone Blood Test?
Testosterone acts on tissue across the whole body, which is why the reasons for testing it stretch well past sex drive.
Androgen receptors sit in muscle, bone, fat tissue, skin, bone marrow, the vascular wall and the brain. Testosterone influences the building and maintenance of lean mass, red blood cell production, bone turnover, fat distribution, mood, motivation and sleep quality. In men, low androgen status has been studied alongside bone health, and work in osteoporotic men compared treatment responses across different androgen levels[2]. Low androgen status has also been examined in relation to lipid patterns, including research in Klinefelter's syndrome describing dyslipidaemia alongside hypogonadism[3].
In women, testosterone is produced in smaller amounts by the ovaries and adrenal glands and still contributes to libido, lean mass, bone density and energy. The clinical interest usually runs the other way, towards androgen excess, where the visible clues tend to be skin and hair related. Research into androgen-dependent skin findings in polycystic ovary syndrome has described how features such as acne and hirsutism cluster with biochemical androgen patterns[4].
Age matters too. Reviews of endocrine ageing in men describe a gradual decline in circulating androgen with age alongside a rise in binding protein, which shifts the free fraction more than the total[5]. None of this makes a single number a diagnosis. It makes the number worth measuring properly.
Getting tested is a short, ordinary process, and most of the quality comes from the preparation rather than the needle. Here is the sequence that gives a result worth interpreting.
Morning, ideally between 7am and 10am, because testosterone follows a daily rhythm that peaks in the early hours and drifts down through the day.
The rhythm is driven by pulsatile signalling from the hypothalamus and pituitary, which is strongest overnight and in the early morning. A sample taken in the late afternoon can land meaningfully below the same person's morning value, which is how an entirely ordinary reading ends up looking suboptimal. If you tested at 4pm and the number came back low, the first question is not what to do about it but when to retest.
The rhythm is not identical for everyone. It tends to be more pronounced in younger men and flatter with age, which is part of the broader endocrine shift described in reviews of male ageing[5]. A flatter rhythm does not make timing irrelevant, it makes consistency more important. Testing at roughly the same hour each time removes one large source of noise when you compare results over months or years.
For women, cycle timing can matter depending on what else is being measured. Testosterone itself varies less across the cycle than oestradiol or progesterone, but if those are on the same panel, the draw is usually scheduled to a specific cycle day chosen by the ordering clinician.
Fasting is not strictly required for testosterone itself, but it is often requested because the same draw usually carries markers that do need it.
Glucose, insulin and a full lipid panel are read more cleanly after an overnight fast, and those markers travel with hormone testing often enough that an overnight fast is the simpler default. If testosterone is the only marker being run, follow whatever instruction your lab prints.
Several other factors are worth controlling because they move results more than people expect.
Start with total testosterone, and add SHBG plus free or bioavailable testosterone when symptoms and the total disagree, or when something is likely to have shifted binding protein levels.
| What is measured | What it reflects |
|---|---|
| Total testosterone | Everything in circulation, bound and unbound together |
| SHBG | The main binding protein, which sets how much hormone stays tightly held |
| Free testosterone | The small unbound fraction, measured directly or calculated from total, SHBG and albumin |
| Bioavailable testosterone | The free fraction plus the loosely albumin-bound portion |
The practical problem is that SHBG moves for many reasons. It tends to rise with age, with thyroid excess, with liver disease and with oestrogen exposure, and it tends to fall with insulin resistance, obesity and some medications. When SHBG is high, total testosterone can look reassuring while the free fraction is low. When SHBG is low, the reverse happens. Biochemical assessments of androgen status have argued for exactly this reason that free or bioavailable measures track the clinical picture more closely than total alone[1].
How free testosterone is obtained also matters. Equilibrium dialysis is the reference method and is more involved; calculated free testosterone, derived from total, SHBG and albumin, is far more common and generally adequate when the inputs are reliable. Direct analogue immunoassays for free testosterone are considered less dependable. If your report lists free testosterone, it is worth knowing which method produced it, because the numbers are not interchangeable between approaches.
Typical adult male total testosterone sits within a wide laboratory reference range, and FitScript's optimal range sits in the upper middle of it.
| Measure | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Total testosterone, adult men | 264 to 1200 ng/dL | 500 to 900 ng/dL |
| Total testosterone, adult women | 8 to 120 ng/dL | 15 to 70 ng/dL |
| Free testosterone | Varies by lab and by method (calculated or equilibrium dialysis) | Interpreted alongside total testosterone and SHBG |
| SHBG | Varies by lab, age and sex | Interpreted alongside total testosterone |
Reference ranges are typical laboratory ranges and vary by lab, assay, age and sex. FitScript's optimal ranges are optimization targets, not diagnostic cut-offs, and sitting outside one is not a diagnosis of anything.
Two details make these numbers easier to read. First, laboratory reference ranges are usually built from a sampled population rather than from a population known to feel and function well, which is why a value can sit inside the range and still be worth a conversation if symptoms are clear. Second, women's total testosterone is measured at concentrations roughly an order of magnitude lower than men's, where ordinary immunoassays lose precision. Mass spectrometry based methods are generally preferred for low concentrations, including in women and children, and the assay used should be visible on the report.
Because testosterone varies within the same person from hour to hour and day to day, and because different assays do not produce identical numbers.
The within-person variation is real and substantial. Pulsatile secretion, sleep quality, recent illness, stress, alcohol and training load all nudge the value. Add the daily rhythm and it becomes easy for one reading to land well away from that person's usual level. This is the reason the conventional approach is to confirm a low or unexpected result with a second morning draw on a separate day before anything is concluded.
Assay variation adds a second layer. Immunoassays and liquid chromatography tandem mass spectrometry can return different values on the same sample, and calibration differs between laboratories. That is why comparing a result from one lab with a range or a friend's result from another lab is not a fair comparison. Where possible, keep repeat testing with the same lab and method so you are tracking your biology rather than a change in instrument.
The third layer is context. A number means something different in a man with poor sleep and an untreated weight problem than in a man with normal sleep, normal thyroid and a family history of early hypogonadism. Observation, then careful inference, then a discussion with a clinician. That order protects you from over-reacting to a figure that was never going to repeat.
A low morning total testosterone, confirmed on a second draw, suggests the hypothalamic-pituitary-gonadal axis is producing or delivering less hormone than usual, and the next step is working out where in that chain the signal is changing.
Clinicians usually separate two patterns using luteinising hormone (LH) and follicle stimulating hormone (FSH). When testosterone is low and LH and FSH are raised, the signal from the pituitary is strong and the testes are responding weakly. When testosterone is low and LH and FSH are low or inappropriately normal, attention moves upstream to the pituitary and hypothalamus, where prolactin, thyroid function, iron studies and pituitary imaging may come into the conversation. Congenital causes also exist, and conditions such as Klinefelter's syndrome have been studied alongside their metabolic associations[3].
Reversible contributors are common and worth taking seriously before anything else. Many of these move in a favourable direction when the underlying issue is addressed.
What it is worth discussing with a clinician is the pattern rather than the single figure. Bring the symptoms, the medication list, your sleep history and both test results. If the result is accompanied by visual changes, severe headaches, breast tissue changes or loss of body hair, that is worth discussing with a clinician promptly rather than at the next routine appointment. Never ignore an abnormal result because a website suggested it might be benign.
A higher than expected testosterone result means different things depending on sex, and the first question is always whether anything is being taken that contains or raises androgens.
In men, markedly high total testosterone most often reflects exogenous hormone from testosterone therapy, over-the-counter products containing undeclared androgens, or a sample drawn soon after a dose. A pattern of high testosterone with suppressed LH and FSH points strongly towards an outside source. Less commonly, androgen-secreting tumours or adrenal conditions are considered, which is why DHEA-S and other adrenal markers are sometimes added. A high reading is also worth checking against haematocrit and oestradiol, since both tend to move when androgen exposure rises.
In women, raised testosterone usually prompts a structured work-up for androgen excess. Polycystic ovary syndrome is the most frequently discussed pattern, and the biochemical criteria for defining hyperandrogenism have been reviewed in detail, including the importance of free rather than total androgen measures[1]. The clinical features that cluster with these biochemical findings often appear in the skin and hair[4]. Adrenal sources, late-onset congenital adrenal hyperplasia and, rarely, androgen-secreting tumours are also part of the differential, which is why DHEA-S, 17-hydroxyprogesterone, LH, FSH and prolactin frequently accompany the testosterone measurement.
Treatment decisions in either direction belong to a licensed provider who has reviewed the whole picture, not to a single number on a page.
The largest everyday influences are sleep, body composition, alcohol, training load, chronic stress and medication, and most of them act on the same signalling axis rather than on the testes directly.
Sleep is the one with the most direct mechanical link, because a large share of testosterone release happens during sleep. Chronic short sleep is associated with lower morning values, and sleep apnoea is both common and under-recognised in men with low results. Body composition matters because adipose tissue contributes to aromatisation of testosterone into oestradiol and because insulin resistance tends to lower SHBG, changing both total and free values. Research in women with PCOS illustrates how closely metabolic and hormonal parameters travel together; meta-analyses of GLP-1 receptor agonists in women with PCOS and obesity have examined weight loss alongside hormonal measures[6], and reviews of ketogenic dietary approaches in the same population have looked at weight, metabolic and endocrine parameters together[7]. Any prescription medication of that kind is something a licensed provider evaluates for appropriateness.
Training is a two-sided factor. Resistance training and adequate protein support lean mass and metabolic health, while sustained excessive volume with inadequate fuelling is associated with suppression of the axis. Chronic psychological stress and heavy alcohol use both work against normal signalling.
Supplements are where expectations usually outrun what is established. A randomised, double-blind, placebo-controlled trial examined maca in men with symptoms of late-onset hypogonadism[8], and a separate study investigated a botanical formulation for its effect on endogenous male sex hormone generation[9]. Each looked at one specific product, and results from one product do not generalise to the category. Correcting a vitamin D or iron deficiency that a blood test has actually identified is a more defensible place to start.
A venous blood draw analysed at an accredited laboratory remains the reference approach, and other sampling methods vary in how closely they track it.
| Method | What it samples | Practical notes |
|---|---|---|
| Venous draw at a lab or phlebotomy site | Serum from a vein | The standard for total testosterone, SHBG, LH and FSH; mass spectrometry methods are preferred at low concentrations |
| At-home finger-prick kit | Capillary blood on a card or in a microtube | Convenient and morning-friendly; accuracy depends on the assay, sample volume and whether the kit is processed by an accredited lab |
| Dried urine testing | Hormone metabolites over a collection window | Gives metabolite information rather than a serum concentration, and is not interchangeable with a serum result |
If you use an at-home kit, treat it as a screening step. Collect in the morning, follow the instructions on sample volume exactly, and check that an accredited laboratory runs the analysis. If the result is low, high or simply does not match how you feel, confirm it with a venous morning draw before acting on it.
The larger limitation of any single-marker home test is context. Total testosterone without SHBG, LH, FSH, oestradiol and a basic metabolic picture answers one narrow question and leaves the useful ones open.
Testosterone is most informative inside a panel, because the surrounding markers tell you where a change is coming from and what it is affecting.
After the result, the work is interpretation and confirmation rather than immediate action, and any treatment decision belongs to a licensed provider who has reviewed your full picture.
A sensible sequence looks like this. Confirm an unexpected result with a second morning draw. Add SHBG and free testosterone if the total and the symptoms do not line up. Add LH, FSH and prolactin if the confirmed total is low. Address the reversible contributors that the rest of the panel reveals, including sleep, body composition, alcohol, medication effects and any deficiency the bloodwork identified. Then retest after enough time has passed for a change to register, and keep the lab and the timing consistent.
Testosterone therapy, hormone therapy in women and peptide therapies are prescription or clinician-gated interventions. A licensed provider evaluates whether any of them is appropriate, taking account of fertility plans, red cell counts, prostate considerations, cardiovascular history and what the repeated labs actually show. Fertility deserves specific mention, because exogenous testosterone suppresses the body's own signalling and can reduce sperm production, which is a conversation to have before starting rather than afterwards.
Some findings deserve a prompt conversation rather than a scheduled one. New visual field changes or severe persistent headaches, breast tissue changes or discharge, testicular changes, a markedly raised haematocrit, or rapid virilising changes in a woman are all worth discussing with a clinician promptly. Always discuss your results and any proposed treatment with a clinician or licensed provider rather than acting on a number alone.
For more detail on the individual markers, the reference pages for Testosterone Total, testosterone free, shbg, estradiol and dhea s explain what each one measures and why it is run, and the overview of hormone panels for men and for women shows how these markers are usually grouped together. FitScript runs them on a recurring schedule as part of 150+ biomarkers tested per year, with interpretation from Atlas, its AI health advisor, and any treatment decision made by a licensed provider.
Check testosterone with a venous blood test drawn in the morning, ideally between 7am and 10am. Ask for total testosterone, and add SHBG and free testosterone if your symptoms and the total do not match. A low or surprising reading is confirmed with a second morning sample before any conclusions are drawn.
Testing is ordered through a primary care clinician, an endocrinologist, a men's or women's health clinic, a direct lab order, or a membership that runs hormone markers on a schedule. The sample is a standard morning blood draw from the arm, and the result is read against the reference range printed on that lab's own report.
Begin with total testosterone, which captures bound and unbound hormone together. If binding proteins are likely to be shifted by age, thyroid status, liver health or insulin resistance, SHBG and free or bioavailable testosterone are added so the available fraction is visible. Your clinician decides which measures the picture needs.
Book a morning draw, sleep normally the night before, avoid very hard training and alcohol in the preceding day or two, pause high-dose biotin, and do not test during an acute illness. Many panels ask for an overnight fast because glucose and lipids travel with them. Repeat at a similar hour for comparable results.
Between 7am and 10am. Testosterone follows a daily rhythm that peaks in the early morning and drifts down through the day, so an afternoon sample can land below your own usual level. The rhythm flattens with age, which makes consistent timing on every repeat test even more useful for tracking change.
Not for testosterone itself, but fasting is often requested because the same draw usually carries glucose, insulin and lipids, which read more cleanly after an overnight fast. Follow the instruction your lab prints. Sleep, alcohol, acute illness and very hard training in the preceding day affect the result more than food does.
At-home finger-prick kits can be useful as a screening step when an accredited laboratory runs the analysis and you collect in the morning with the correct sample volume. A venous draw remains the reference approach, particularly at the lower concentrations seen in women. Confirm any low, high or unexpected home result with a lab draw.
A low or unexpected result is confirmed with a second morning draw on a separate day. After that, retesting frequency depends on what is being changed and why, so it is set by the clinician managing your care. Keeping the same lab, method and time of day makes repeat results genuinely comparable.